Skip to content
EmergingResearch compoundModerate evidence

9‑Me‑BC

Beta-carboline alkaloid. MAO-B inhibitor + neurotrophic, dopaminergic motivation nootropic (in vitro data).

NootropicDopaminergicNeuroprotectionMemoryDopamineBDNF
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassDopaminergic · Neuroprotection · Memory
Primary targetMAO-B enzyme (monoamine oxidase B)
Targets4 receptor targets
Half-life12-24 h (estimated)
Onset60-120 min
EvidenceModerate evidence
Affected systemsDopamineBDNF

Contents

WHAT IS 9-ME-BC?

Detailed overview

9-Methyl-β-carboline (9-Me-BC) is a beta-carboline alkaloid derivative, a small-molecule MAO-B (monoamine oxidase B) inhibitor + neurotrophic factor (BDNF, GDNF) expression-elevator. Dopaminergic neuron protection is documented in vitro and animal models; human data is sparse. Research-only in all regions, no clinical trial status. The β-carboline backbone occurs naturally in plants (Banisteriopsis caapi, Peganum harmala) as a MAO-A inhibitor, 9-methylation increases B-selectivity and blood-brain-barrier permeability.

Mechanism

MAO-B inhibitor + neurotrophic

Half-life

12-24 h (estimated, human data sparse)

Onset

60-120 min

Legal status

Global research only

Receptor profile

  • MAO-B enzymeStrong
  • BDNF / GDNF neurotrophic factorsStrong
  • Dopamine synthesis (tyrosine hydroxylase, AADC)Moderate
  • Hippocampal neurogenesisModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Limited human safety data: most effects derive from in vitro and animal models
  • Photosensitivity, faster sunburn (beta-carboline scaffold interacts with UV light)
  • Emotional blunting or flattening after prolonged use (anecdotal)
  • Dopaminergic overstimulation: restlessness, insomnia, stimulant-like feel at higher doses
  • Possible tyramine reaction (MAO-B selective, but not zero risk): headache, blood pressure rise
  • Unknown long-term safety, chronic daily use uncharacterized

Contraindications · 6

  • Do not combine with MAOIs, SSRIs, SNRIs: risk of serotonin syndrome and hypertensive crisis
  • Avoid tyramine-rich foods (aged cheese, red wine, cured meat) during use
  • Avoid direct UV/sun exposure (photosensitivity): SPF 50+ recommended
  • Additive dopaminergic overstimulation with stimulants: do not combine with stimulants
  • Avoid during pregnancy and breastfeeding (no safety data)
  • Avoid in active psychiatric crisis or mania spectrum

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

9-Me-BC is a beta-carboline-type alkaloid being studied because in lab experiments it raised dopamine activity and helped protect dopamine-producing nerve cells, which is why users try it for motivation, focus, or as a "dopamine detox" after heavy stimulant use. Human experience so far is only anecdotal, there's no serious clinical trial behind it.

Telegram

Have a question about 9‑Me‑BC?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC13H12N2
UpdatedJune 19, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.